Ionis Pharmaceuticals (IONS) Change in Acquisitions & Divestments (2016 - 2025)
Ionis Pharmaceuticals (IONS) has 17 years of Change in Acquisitions & Divestments data on record, last reported at $395.1 million in Q4 2025.
- For Q4 2025, Change in Acquisitions & Divestments fell 8.09% year-over-year to $395.1 million; the TTM value through Dec 2025 reached $1.7 billion, down 4.03%, while the annual FY2025 figure was $1.7 billion, 4.03% down from the prior year.
- Change in Acquisitions & Divestments reached $395.1 million in Q4 2025 per IONS's latest filing, down from $422.2 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $600.8 million in Q1 2024 and bottomed at $178.8 million in Q1 2022.
- Average Change in Acquisitions & Divestments over 5 years is $369.3 million, with a median of $379.0 million recorded in 2022.
- Peak YoY movement for Change in Acquisitions & Divestments: plummeted 56.58% in 2022, then soared 109.33% in 2023.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $292.3 million in 2021, then decreased by 23.01% to $225.1 million in 2022, then soared by 73.72% to $391.0 million in 2023, then increased by 9.96% to $429.9 million in 2024, then fell by 8.09% to $395.1 million in 2025.
- Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $395.1 million in Q4 2025, $422.2 million in Q3 2025, and $385.8 million in Q2 2025.